Campylobacter jejuni Detection

Comprehensive Campylobacter jejuni Detection and Characterisation Services – From Conventional Culture to Molecular Subtyping and Genomic Epidemiology

The accurate and rapid detection of Campylobacter jejuni in food, water, environmental samples, and clinical specimens is a cornerstone of public health surveillance, regulatory compliance, and industrial quality assurance. As the leading bacterial cause of gastroenteritis worldwide, with an estimated 400–500 million cases annually, C. jejuni is subject to stringent monitoring programmes and regulatory limits in many countries. Regulatory frameworks such as ISO 10272 (food microbiology), FDA BAM Chapter 7, and national health protection agencies mandate specific enumeration or presence/absence criteria for high‑risk food products (e.g., poultry, unpasteurised milk, and raw meat). However, the practical performance of a testing strategy is not defined by a single method; it is critically dependent on the sample matrix, the physiological state of the organism (viable, stressed, or viable‑but‑non‑culturable), the presence of competing microflora, and the required turnaround time for product release or outbreak response. Routine culture‑based methods, such as selective plating on modified charcoal cefoperazone deoxycholate (mCCDA) agar, provide the gold‑standard confirmation, but they are time‑consuming (requiring 48‑72 hours) and often underestimate stressed cells. Furthermore, conventional culture does not differentiate between pathogenic and non‑pathogenic strains, nor does it provide information on antimicrobial resistance or epidemiological linkage. Consequently, advanced analytical capabilities – including real‑time PCR, immunomagnetic separation (IMS), matrix‑assisted laser desorption/ionisation time‑of‑flight mass spectrometry (MALDI‑TOF MS), multi‑locus sequence typing (MLST), and whole‑genome sequencing (WGS) – are increasingly required for effective surveillance, source tracking, and risk management. Our ISO/IEC 17025‑accredited microbiology laboratory offers a fully integrated, multi‑method testing platform specifically designed for C. jejuni analysis, covering the entire spectrum from classical isolation and biochemical confirmation to rapid molecular detection, speciation, subtyping, virulence gene profiling, antimicrobial susceptibility testing, and high‑resolution genotyping – delivering quantitative, traceable data that directly support regulatory compliance, outbreak investigation, food safety management, and public health interventions.

1. Scientific and Regulatory Context for Campylobacter jejuni Testing

C. jejuni is a microaerophilic, Gram‑negative, spiral‑shaped bacterium that is widely distributed in the intestinal tracts of poultry, cattle, and wild birds. It is a leading cause of foodborne illness, with symptoms ranging from mild diarrhoea to severe, sometimes life‑threatening, post‑infectious complications such as Guillain‑Barré syndrome and reactive arthritis. Regulatory limits are stringent: for example, in the EU, Regulation (EC) No 2073/2005 sets a maximum of 1,000 CFU/g for fresh broiler meat, and zero tolerance for certain ready‑to‑eat foods. The choice of analytical method – whether ISO 10272‑1 (detection), ISO 10272‑2 (enumeration), or rapid alternative methods – must be tailored to the sample matrix, the expected bacterial load, and the urgency of the result. Additionally, the need to differentiate C. jejuni from other Campylobacter species (e.g., C. coli, C. lari) and to assess virulence markers (e.g., the wlaN gene for Guillain‑Barré syndrome) demands a comprehensive approach. Our service begins with a detailed consultation to design a testing protocol that aligns with your regulatory requirements, product characteristics, and decision‑making timelines.

2. Our Comprehensive Analytical Platform – Classical, Biochemical, and Molecular Methods

We maintain a complete suite of reference and alternative methods, all performed under strictly controlled microaerophilic conditions and with certified reference strains (e.g., C. jejuni ATCC 33560, ATCC 33291) for quality control. Our testing portfolio includes:

2.1 Classical Culture – ISO 10272 and FDA BAM
We adhere to ISO 10272‑1 and ISO 10272‑2, which include primary enrichment in Bolton broth or selective enrichment in Preston broth, followed by plating on modified charcoal cefoperazone deoxycholate (mCCDA) agar and incubation at 41.5 °C under microaerobic conditions (5% O₂, 10% CO₂, 85% N₂) for 48 hours. Suspect colonies (grey, moist, flat) are confirmed by oxidase, catalase, and hippurate hydrolysis tests, and by phase‑contrast microscopy for characteristic darting motility. We provide quantitative counts (CFU/g or CFU/mL) with detection limits as low as 10 CFU/g, and we include statistical uncertainty (expanded uncertainty at k=2).

2.2 Most Probable Number (MPN) Technique – For Low‑Level Contamination
For samples with very low counts or high background flora, we employ the MPN method using selective broth and confirmatory plating on mCCDA. The MPN index is calculated with a 95% confidence interval, providing a reliable estimate even for samples where colony counting is challenging.

2.3 Immunomagnetic Separation (IMS) – Concentration and Purification
We use magnetic beads coated with anti‑Campylobacter antibodies to selectively capture and concentrate C. jejuni from complex matrices (e.g., food homogenates, water), significantly improving sensitivity and reducing background interference. This is particularly useful for samples with low contamination levels.

2.4 Biochemical and Proteomic Identification
For definitive species identification, we use commercial identification systems such as API Campy, VITEK 2 GN cards, or MALDI‑TOF MS, which provides species‑level identification with a high confidence score (> 2.0). For rare or ambiguous isolates, we perform 16S rRNA gene sequencing to confirm the species.

2.5 Real‑Time Polymerase Chain Reaction (qPCR) – Rapid and Specific Detection
For urgent screening or when rapid results are essential, we perform real‑time PCR targeting the mapA (catalase) gene for C. jejuni or the 16S rRNA gene for genus‑level detection. Our assay includes an internal amplification control (IAC) to detect inhibition and incorporates propidium monoazide (PMA) treatment to selectively amplify DNA from viable cells, reducing false‑positive signals from dead cells. The detection limit is ≤ 10 CFU per reaction, with results available in 3‑4 hours after DNA extraction. This method is validated according to ISO 22174 and is ideal for high‑throughput screening.

2.6 Droplet Digital PCR (ddPCR) – Absolute Quantification
For accurate enumeration without the need for a standard curve, we offer ddPCR targeting the mapA gene, providing absolute copy‑number determination. This is particularly valuable for low‑level contamination and for validation of processing steps.

3. Advanced Characterisation – Speciation, Virulence Profiling, and Genomic Epidemiology

For clients requiring detailed strain characterisation – whether for outbreak investigation, source tracking, or risk assessment – we offer a suite of cutting‑edge, research‑grade analytical services that go beyond routine detection:

3.1 Speciation – Differentiation from Other Campylobacter Species
Using multiplex PCR or MALDI‑TOF MS, we reliably distinguish C. jejuni from C. coli, C. lari, C. upsaliensis, and other species, which is essential for epidemiological and clinical purposes.

3.2 Virulence Gene Profiling – Pathogenicity and Guillain‑Barré Syndrome (GBS) Risk Markers
We screen for key virulence genes using PCR or WGS: cadF (fibronectin binding), flaA (flagellin), ciaB (invasion), and the wlaN gene, which is associated with the production of the sialylated lipo‑oligosaccharide (LOS) that mimics gangliosides, a risk factor for GBS. This profile enables a refined risk assessment.

3.3 Antimicrobial Resistance (AMR) Testing – MIC Determination and Genotypic Resistance
We determine minimum inhibitory concentrations (MICs) for a panel of clinically and veterinary relevant antibiotics (e.g., ciprofloxacin, erythromycin, tetracycline, gentamicin, and chloramphenicol) using broth microdilution according to CLSI M45‑A2 guidelines. We also screen for the most common resistance genes (tet, erm, gyrA mutations) by PCR or WGS, supporting surveillance and therapeutic decisions.

3.4 High‑Resolution Subtyping – PFGE, MLST, and Whole‑Genome Sequencing
For outbreak investigation and source tracking, we perform Pulsed‑Field Gel Electrophoresis (PFGE) using KpnI and SalI digestion, following PulseNet protocols. The resulting fingerprints can be compared with national databases. For the highest discriminatory power, we offer multi‑locus sequence typing (MLST) (based on seven housekeeping genes) and WGS with core‑genome MLST (cgMLST) and single‑nucleotide polymorphism (SNP) analysis, enabling precise differentiation and linkage to environmental sources or clinical cases.

3.5 Viability and Injury Detection – PMA‑qPCR and Resuscitation Assays
We combine PMA‑qPCR with culture‑based resuscitation on non‑selective media to quantify viable cells, including those that are sub‑lethally injured and might be missed by direct plating. This provides a realistic assessment of the true population after processing or disinfection.

3.6 Biofilm and Stress Resistance Testing
We evaluate the ability of C. jejuni to form biofilms under different conditions and assess its resistance to acid, heat, and oxidative stress, providing data for the design of effective control strategies.

4. Data Integrity, Standardisation, and Comprehensive Reporting

All analyses are conducted under a strict quality management system with daily controls, certified reference cultures, and participation in international proficiency testing (e.g., FAPAS, APHL). Our reports deliver: - Full method description (sample pre‑treatment, enrichment, selective media, incubation parameters, and confirmation criteria). - Quantitative results (CFU/g, CFU/mL, or MPN) with expanded uncertainty (k=2) and detection limits. - Identification confirmation (biochemical profile, API code, MALDI‑TOF score, or PCR result). - Speciation and virulence gene profile – presence/absence of key genes and interpretation of pathogenic potential. - Antimicrobial susceptibility data (MIC values and categorical interpretation, S/I/R). - Genotyping outputs – PFGE patterns, MLST allele profiles, or WGS‑based cgMLST/SNP distances, with comparative analysis where available. - Viability and injury assessment (if requested). - Actionable recommendations for corrective actions, process optimisation, and source identification.

Our reports are authored by senior food and clinical microbiologists who provide not just raw data, but interpretive insights that help you understand the significance of the results, the likely source of contamination, and the effectiveness of your control measures. We also offer method validation and customised sampling plans for unusual or challenging matrices.

Turnaround times: 2‑3 days for enumeration and isolation, 24‑48 hours for qPCR screening, 3‑4 days for speciation and virulence profiling, and 5‑7 days for PFGE, MLST, or WGS analysis. Express services are available for emergency outbreaks.

5. Our Unmatched Expertise – Why Choose Our Laboratory for Campylobacter jejuni Testing

We are one of the few laboratories that hold ISO/IEC 17025 accreditation for the detection, enumeration, speciation, and antimicrobial susceptibility testing of C. jejuni according to ISO 10272, FDA BAM, and CLSI guidelines. Our integrated infrastructure combines classical microbiology, immunological methods (IMS), proteomic identification (MALDI‑TOF MS), molecular diagnostics (qPCR, ddPCR), and advanced genotyping (MLST, PFGE, WGS) – enabling cross‑method verification and rapid resolution of ambiguous results. Our team comprises PhD‑level microbiologists, bioinformaticians, and food safety experts with extensive experience in food microbiology, outbreak investigation, and veterinary surveillance, and we have a proven track record of supporting regulatory audits and legal proceedings with robust, defensible data.

We offer unparalleled flexibility: we accept samples from all types of food, water, environmental swabs, and clinical specimens. We provide customised sampling kits with appropriate transport media (e.g., Cary‑Blair) to preserve viability. Our secure online portal enables real‑time tracking, access to raw data, and trend reporting.

Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a simple enumeration to full genomic characterisation – with discounts for routine monitoring programmes and bulk submissions. We also provide training, inter‑laboratory comparison, and technical consultancy to help you strengthen your in‑house testing and control programmes.

With a proven history of serving over 80 food manufacturers, water utilities, and public health agencies, we have enabled our partners to meet regulatory requirements, detect contamination early, trace the source effectively, and implement corrective measures efficiently. We invite you to leverage our expertise for your Campylobacter jejuni testing needs.

Contact our technical experts today to discuss your sample types, regulatory targets, and required turn‑around times. We will design a tailored testing plan and provide a detailed proposal within one business day.